{"id":"https://openalex.org/W2590513344","doi":"https://doi.org/10.1200/jco.2011.29.15_suppl.e15131","title":"Impact of G-CSF prophylaxis on the occurrence of neutropenia in patients with metastatic castration-resistant prostate cancer (mCRPC) receiving cabazitaxel.","display_name":"Impact of G-CSF prophylaxis on the occurrence of neutropenia in patients with metastatic castration-resistant prostate cancer (mCRPC) receiving cabazitaxel.","publication_year":2011,"publication_date":"2011-05-20","ids":{"openalex":"https://openalex.org/W2590513344","doi":"https://doi.org/10.1200/jco.2011.29.15_suppl.e15131","mag":"2590513344"},"language":"en","primary_location":{"id":"doi:10.1200/jco.2011.29.15_suppl.e15131","doi":"https://doi.org/10.1200/jco.2011.29.15_suppl.e15131","is_oa":false,"landing_page_url":"https://doi.org/10.1200/jco.2011.29.15_suppl.e15131","pdf_url":null,"source":{"id":"https://openalex.org/S15137598","display_name":"Journal of Clinical Oncology","issn_l":"0732-183X","issn":["0732-183X","1527-7755"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310315671","host_organization_name":"Lippincott Williams & Wilkins","host_organization_lineage":["https://openalex.org/P4310315671","https://openalex.org/P4310318547"],"host_organization_lineage_names":["Lippincott Williams & Wilkins","Wolters Kluwer"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of Clinical Oncology","raw_type":"journal-article"},"volume":null,"type":"conference-abstract","indexed_in":["crossref"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5023874099","display_name":"Mustafa \u00d6zg\u00fcro\u011flu","orcid":"https://orcid.org/0000-0002-8417-8628","observed_orcids":["https://orcid.org/0000-0002-8417-8628"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"M. Ozguroglu","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5059690857","display_name":"St\u00e9phane Marie. Oudard","orcid":"https://orcid.org/0000-0003-0893-285X","observed_orcids":["https://orcid.org/0000-0003-0893-285X"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"S. Oudard","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5073246821","display_name":"Oliver A. Sartor","orcid":"https://orcid.org/0000-0002-8777-7343","observed_orcids":["https://orcid.org/0000-0002-8777-7343"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"A. O. Sartor","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5061521917","display_name":"Steinbj\u00f8rn Hansen","orcid":"https://orcid.org/0000-0001-5651-6493","observed_orcids":["https://orcid.org/0000-0001-5651-6493"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"S. Hansen","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5110314055","display_name":"J. H. Machiels","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"J. H. Machiels","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5050901329","display_name":"Liji Shen","orcid":"https://orcid.org/0000-0003-0671-1041","observed_orcids":["https://orcid.org/0000-0003-0671-1041"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"L. Shen","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5072378199","display_name":"Johann Sebastian De Bono","orcid":"https://orcid.org/0000-0002-2034-595X","observed_orcids":["https://orcid.org/0000-0002-2034-595X"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"J. S. De Bono","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"last","author":{"id":null,"display_name":"For the TROPIC investigators","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"For the TROPIC investigators","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]}],"institutions":[],"countries_distinct_count":0,"institutions_distinct_count":0,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":null,"has_fulltext":false,"cited_by_count":2,"citation_normalized_percentile":null,"cited_by_percentile_year":null,"biblio":{"volume":"29","issue":"15_suppl","first_page":"e15131","last_page":"e15131"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T12172","display_name":"Neutropenia and Cancer Infections","score":0.9047999978065491,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T12172","display_name":"Neutropenia and Cancer Infections","score":0.9047999978065491,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10543","display_name":"Prostate Cancer Treatment and Research","score":0.0697999969124794,"subfield":{"id":"https://openalex.org/subfields/2740","display_name":"Pulmonary and Respiratory Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11752","display_name":"Cancer Treatment and Pharmacology","score":0.009999999776482582,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/g-csf-prophylaxis","display_name":"G-CSF prophylaxis","score":0.8809999823570251},{"id":"https://openalex.org/keywords/neutropenia","display_name":"neutropenia","score":0.9580000042915344},{"id":"https://openalex.org/keywords/febrile-neutropenia","display_name":"febrile neutropenia","score":0.9470000267028809},{"id":"https://openalex.org/keywords/metastatic-castration-resistant-prostate-cancer","display_name":"metastatic castration-resistant prostate cancer","score":0.9890000224113464},{"id":"https://openalex.org/keywords/cabazitaxel","display_name":"cabazitaxel","score":0.9980000257492065},{"id":"https://openalex.org/keywords/prednisone","display_name":"prednisone","score":0.8539999723434448},{"id":"https://openalex.org/keywords/mitoxantrone","display_name":"mitoxantrone","score":0.9290000200271606},{"id":"https://openalex.org/keywords/tropic-trial","display_name":"TROPIC trial","score":0.9240000247955322},{"id":"https://openalex.org/keywords/chemotherapy-induced-neutropenia","display_name":"chemotherapy-induced neutropenia","score":0.7950000166893005},{"id":"https://openalex.org/keywords/dose-reduction","display_name":"dose reduction","score":0.5789999961853027},{"id":"https://openalex.org/keywords/granulocyte-colony-stimulating-factor","display_name":"granulocyte colony-stimulating factor","score":0.6919999718666077},{"id":"https://openalex.org/keywords/prognostic-factors","display_name":"prognostic factors","score":0.5419999957084656},{"id":"https://openalex.org/keywords/prognostic-score","display_name":"prognostic score","score":0.43299999833106995}],"concepts":[{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.9235473871231079},{"id":"https://openalex.org/C2780923524","wikidata":"https://www.wikidata.org/wiki/Q239426","display_name":"Mitoxantrone","level":3,"score":0.8060774207115173},{"id":"https://openalex.org/C2781190966","wikidata":"https://www.wikidata.org/wiki/Q420436","display_name":"Docetaxel","level":3,"score":0.8042739629745483},{"id":"https://openalex.org/C2778971682","wikidata":"https://www.wikidata.org/wiki/Q412963","display_name":"Cabazitaxel","level":5,"score":0.7737313508987427},{"id":"https://openalex.org/C2777063308","wikidata":"https://www.wikidata.org/wiki/Q1435822","display_name":"Neutropenia","level":3,"score":0.7687923312187195},{"id":"https://openalex.org/C2778850193","wikidata":"https://www.wikidata.org/wiki/Q3775974","display_name":"Febrile neutropenia","level":4,"score":0.7569268941879272},{"id":"https://openalex.org/C2777767877","wikidata":"https://www.wikidata.org/wiki/Q419327","display_name":"Granulocyte colony-stimulating factor","level":3,"score":0.6061201095581055},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.5993983149528503},{"id":"https://openalex.org/C2776694085","wikidata":"https://www.wikidata.org/wiki/Q974135","display_name":"Chemotherapy","level":2,"score":0.5717516541481018},{"id":"https://openalex.org/C2778720950","wikidata":"https://www.wikidata.org/wiki/Q424972","display_name":"Prednisone","level":2,"score":0.5373330116271973},{"id":"https://openalex.org/C2780192828","wikidata":"https://www.wikidata.org/wiki/Q181257","display_name":"Prostate cancer","level":3,"score":0.4410557746887207},{"id":"https://openalex.org/C90924648","wikidata":"https://www.wikidata.org/wiki/Q120569","display_name":"Gastroenterology","level":1,"score":0.40447506308555603},{"id":"https://openalex.org/C141071460","wikidata":"https://www.wikidata.org/wiki/Q40821","display_name":"Surgery","level":1,"score":0.3679719865322113},{"id":"https://openalex.org/C121608353","wikidata":"https://www.wikidata.org/wiki/Q12078","display_name":"Cancer","level":2,"score":0.23179078102111816},{"id":"https://openalex.org/C2777899217","wikidata":"https://www.wikidata.org/wiki/Q4759439","display_name":"Androgen deprivation therapy","level":4,"score":0.06192907691001892}],"mesh":[],"locations_count":1,"locations":[{"id":"doi:10.1200/jco.2011.29.15_suppl.e15131","doi":"https://doi.org/10.1200/jco.2011.29.15_suppl.e15131","is_oa":false,"landing_page_url":"https://doi.org/10.1200/jco.2011.29.15_suppl.e15131","pdf_url":null,"source":{"id":"https://openalex.org/S15137598","display_name":"Journal of Clinical Oncology","issn_l":"0732-183X","issn":["0732-183X","1527-7755"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310315671","host_organization_name":"Lippincott Williams & Wilkins","host_organization_lineage":["https://openalex.org/P4310315671","https://openalex.org/P4310318547"],"host_organization_lineage_names":["Lippincott Williams & Wilkins","Wolters Kluwer"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of Clinical Oncology","raw_type":"journal-article"}],"best_oa_location":null,"sustainable_development_goals":[{"display_name":"Good health and well-being","score":1.0,"id":"https://metadata.un.org/sdg/3"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W2560808396","https://openalex.org/W3120748849","https://openalex.org/W2062392807","https://openalex.org/W2761912253","https://openalex.org/W2261919111","https://openalex.org/W1951193173","https://openalex.org/W7157860739","https://openalex.org/W2167726449","https://openalex.org/W2803819226","https://openalex.org/W2086412457"],"abstract_inverted_index":{"e15131^":[0],"Background:":[1],"The":[2,220,313],"Phase":[3],"III":[4],"TROPIC":[5],"trial":[6],"demonstrated":[7],"that":[8],"cabazitaxel":[9],"plus":[10,19],"prednisone":[11,20],"(CbzP)":[12],"improved":[13],"overall":[14],"survival":[15],"compared":[16,65],"with":[17,24,66,78,99,119,144,191,206,326],"mitoxantrone":[18],"(MP)":[21],"in":[22,46,95,126,225,253,281,307],"patients":[23,69,252,277],"mCRPC":[25,100,327],"who":[26,102,257,278],"progressed":[27,103],"during":[28,104,260],"or":[29,105,114,161],"after":[30,106,168],"docetaxel-based":[31],"therapy":[32],"(HR":[33],"0.70;":[34],"p":[35,246],"<":[36,247],"0.0001)":[37],"(Lancet":[38],"2010;":[39],"376:1147\u201354).":[40],"A":[41],"higher":[42],"proportion":[43],"of":[44,90,142,158,178,204,222,305,330],"men":[45,308],"the":[47,88,202,250,254,261,275,301],"CbzP":[48,112,223,255,310],"group":[49,256],"had":[50,258,279],"Grade":[51,207,227],"\u2265":[52,208,228],"3":[53,156,166,209,229,284],"neutropenia":[54,60,94,122,143,210,230,306],"(82%":[55],"vs.":[56,63,244],"58%)":[57],"and":[58,188,269,292,303],"febrile":[59],"(FN)":[61],"(8%":[62],"1%)":[64],"MP.":[67],"In":[68,193,274],"clinically":[70],"predisposed":[71],"to":[72,110],"neutropenia,":[73],"ASCO":[74],"guidelines":[75],"recommend":[76],"prophylaxis":[77,118,240,338],"granulocyte-colony":[79],"stimulating":[80],"factor":[81],"(G-CSF)":[82],"and/or":[83],"dose":[84,160],"reductions.":[85],"We":[86],"analyzed":[87],"effect":[89,334],"G-CSF":[91,120,130,147,187,199,236,268,286,298,337],"use":[92,131,148,267,299],"on":[93],"TROPIC.":[96],"Methods:":[97],"Men":[98],"(n=755)":[101],"docetaxel":[107],"were":[108,182,211,317],"randomized":[109],"receive":[111,336],"(n=378)":[113],"MP":[115],"(n=377).":[116],"Primary":[117],"for":[121,311],"was":[123,132,149,200,231,233,237,321],"not":[124,266],"allowed":[125],"cycle":[127,135,173],"1,":[128],"but":[129],"permitted":[133],"from":[134],"2":[136,174],"onward":[137],"following":[138],"a":[139,176],"first":[140,262],"occurrence":[141],"protocol-defined":[145],"complications.":[146],"classified":[150],"as":[151,239,323,339],"prophylactic":[152,198],"if":[153,163],"administered":[154,164],"within":[155],"days":[157,167],"chemotherapy":[159,169,180],"therapeutic":[162,272,290],">":[165],"dose.":[170],"Results:":[171],"From":[172],"onward,":[175],"total":[177],"3246":[179],"cycles":[181,194,205,224,282],"administered,":[183],"2322":[184],"(72%)":[185],"without":[186],"924":[189],"(28%)":[190],"G-CSF.":[192,273,296],"2\u201310":[195],"(in":[196],"which":[197,226],"allowed),":[201],"percentages":[203],"similar":[212],"between":[213],"treatment":[214,343],"groups":[215],"(39%":[216],"CbzP;":[217],"36%":[218],"MP).":[219],"percentage":[221],"observed":[232],"lower":[234],"when":[235,319],"used":[238],"versus":[241],"therapeutically":[242],"(25%":[243],"58%;":[245],"0.0001).":[248],"Of":[249],"17":[251],"FN":[259,280],"cycle,":[263],"9":[264],"did":[265],"8":[270],"received":[271,285,289,294],"11":[276],"2\u201310,":[283],"prophylaxis,":[287],"4":[288,293],"G-CSF,":[291],"no":[295],"Conclusions:":[297],"reduced":[300],"incidence":[302],"severity":[304],"receiving":[309],"mCRPC.":[312],"most":[314],"pronounced":[315],"effects":[316],"noted":[318],"it":[320],"given":[322],"prophylaxis.":[324],"Patients":[325],"at":[328],"risk":[329],"this":[331],"predictable":[332],"side":[333],"should":[335],"recommended":[340],"by":[341],"current":[342],"guidelines.":[344]},"counts_by_year":[{"year":2014,"cited_by_count":1},{"year":2012,"cited_by_count":1}],"updated_date":"2026-09-22T06:50:58.402377","created_date":"2017-03-03T00:00:00"}